Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension

Levosimendan as a calcium-sensitizer is a promising innovative therapeutical option for the treatment of severe cardiac dysfunction (CD) and pulmonary hypertension (PH) in preterm infants, but no data are available analyzing levosimendan in cohorts of preterm infants. The design/setting of the evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Lukas, Holcher, Stanley, Leyens, Judith, Geipel, Annegret, Strizek, Brigitte, Dresbach, Till, Mueller, Andreas, Kipfmueller, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354130/
https://www.ncbi.nlm.nih.gov/pubmed/37100959
http://dx.doi.org/10.1007/s00431-023-04971-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354130/
https://www.ncbi.nlm.nih.gov/pubmed/37100959
http://dx.doi.org/10.1007/s00431-023-04971-9

Ejemplares similares